Live feed
Filing
SC 13G
SC 13G0001213900-22-006090·LAV Biosciences Fund V, L.P.
Schedule 13G ownership disclosure
Terns Pharmaceuticals Inc
Security class unavailable · CUSIP: 880881107
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,392,857
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-22-006090
- Form type
- SC 13G
- Filer
- LAV Biosciences Fund V, L.P.
- CIK
- CIK 1764435
- Filed
- Feb 09, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership